Growing number of elderly people who are prone to infectious diseases, increasing awareness about early diagnosis, high demand for PoC diagnosis due to epidemics, rising infectious diseases are major factors driving the market in the forecast period. The growing aging population worldwide and numerous untapped opportunities in developing countries are expected to boost the growth of the industry during the forecast period. According to World Bank Group estimates that in 2022 there were approximately 779 million people aged 65 & older worldwide. In addition, the number of individuals aged 80 and older is expected to more than double in 2050. The rise of infectious diseases is an important driver of rapid income. Moreover, it must be done routine screening of adults to avoid serious infections.
Infectious Disease Diagnostics Market size was valued at USD 22.6 billion in 2023 and is poised to grow from USD 24.32 billion in 2024 to USD 43.69 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).
Increased regulatory scrutiny of the infectious disease diagnostics market as well. The regulatory framework for drug approval has always been one of the major inhibitors in the clinical research industry. The regulatory framework for the research sector is very strict in countries where the market has great potential for growth due to the large patient pool. Such sporadic and uncertain regulatory processes for in vitro diagnostics confuse manufacturers for commercial purposes.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/infectious-disease-diagnostics-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Infectious Disease Diagnostics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Infectious Disease Diagnostics Market is segmented by Product, Type of Testing, Sample Type, Disease Type, Technology, End User and region.
Based on Product, the market is segmented into Reagents, Kits, And Consumables, Instruments and Software & Services.
Based on Type of Testing, the market is segmented into Laboratory Testing and POC Testing.
Based on Sample Type, the market is segmented into Blood, Serum, And Plasma, Urine and Other Sample Types.
Based on Disease Type, the market is segmented into Hepatitis, HIV, Hospital-Acquired Infections, Mosquito-Borne Diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis and Other Infectious Diseases.
Based on Technology, the market is segmented into Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarray and Other Technologies.
Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes and Other End Users.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Infectious Disease Diagnostics Market – Regional Analysis:
North America region in the infectious disease diagnostics market accounted for 38.49% of the global market in 2023. The industry is expected to keep expanding at lucrative growth during the forecast period with favorable & flexible regulatory framework. Presence of major manufacturers offering new IVD products, more testing and focus on disease management are the major factors driving the North America region.
Asia Pacific is anticipated to witness significant Infectious Disease Diagnostics Market growth due to the high prevalence of infectious diseases, and the increasing demand for healthcare in emerging economies such as India and China are fueling the growth of the sector. The growing elderly population in countries such as Japan is also acting as a catalyst for the adoption of IVD screening.
Top Market Players in Infectious Disease Diagnostics Market are:
F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott (US)
bioMerieux (France)
Siemens Healthineers AG (Germany)
Danaher (US)
Thermo Fisher Scientific Inc. (US)
Hologic, Inc. (US)
Becton, Dickinson and Company (US)
Revvity (US)
Qiagen (Netherlands)
Seegene Inc. (South Korea)
QuidelOrtho Corporation (US)
Grifols, S.A. (Spain)
DiaSorin S.p.A. (Italy)
Bio-Rad Laboratories, Inc. (US)
Sysmex Corporation (Japan)
OraSure Technologies (US)
Co-Diagnostics, Inc. (US)
Trinity Biotech (Ireland)
Genetic Signatures Ltd. (Australia)
Infectious Disease Diagnostics Market Recent Developments:
In March 2024, SEKISUI Diagnostics, a global leader in the development of medical diagnostics, received an EUA license for the OSOM Flu SARS-CoV-2 Combo Test and has been approved for use in both commercial and home testing environments.
In October 2023, Tangen Biosciences and SD Biosensors received an Early Use Authorization (EUA) from the US. at the FDA.
In August 2023, BD will offer U.S. submitted a patent application with the Respiratory Viral Panel for the BD MAX System.
In April 2023, EliTech announced plans to launch ELITE InGenius in 2024. EliVerse is an innovative high-performance molecular diagnostic device for more than 50 CE-IVD parameters.
You may Also Like
https://medium.com/@kathan.trivedi/energy-drinks-market-trends-growth-opportunities-and-future-outlook-e1051479ba6e
https://medium.com/@kathan.trivedi/%EC%9E%A5%EA%B8%B0-%EC%B9%A9-%EC%8B%9C%EC%9E%A5-%EB%8F%99%ED%96%A5-%EC%84%B1%EC%9E%A5-%EA%B8%B0%ED%9A%8C-%EB%B0%8F-%EB%AF%B8%EB%9E%98-%EC%A0%84%EB%A7%9D-3f6dcb255ce7
Forward-Looking Insights
The Infectious Disease Diagnostics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]”
